Peringkat dalam Saham
#41406
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Harga Saham
$0.0003
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$21.97K
Perubahan (1 tahun)
200.00%
Perdagangan MabCure Inc. (MBCI)
Harga MBCI dengan kapitalisasi pasar B
Kapitalisasi pasar dari MabCure Inc.(MBCI)
Kapitalisasi Pasar: $21.97K
Per August 2026, MabCure Inc. memiliki kapitalisasi pasar sebesar $21.97K. Ini menjadikan MabCure Inc. sebagai perusahaan 41406th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar MabCure Inc. dari 2007 hingga 2026
MBCI dibandingkan dengan 5 teratas stocks paling populer
| Harga MBCI |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.383T
|
+24,508,807,134.32%
|
|
|
|
|
$4.423T
|
+20,138,362,039.83%
|
|
|
|
|
$4.160T
|
+18,940,903,323.46%
|
|
|
|
|
$3.663T
|
+16,677,991,570.18%
|
|
|
|
|
$2.891T
|
+13,162,890,051.27%
|
